FDA issues warning to Curaleaf for 'illegally selling' CBD products with 'unsubstantiated claims'

Indonesia Berita Berita

FDA issues warning to Curaleaf for 'illegally selling' CBD products with 'unsubstantiated claims'
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 CNBC
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 72%

The Food and Drug Administration issued a warning letter to Curaleaf for allegedly 'illegally selling' CBD products with 'unsubstantiated claims' like the products treating cancer, Alzheimer's disease, opioid withdrawal, pain and pet anxiety.

for allegedly "illegally selling" CBD products with "unsubstantiated claims" like the products treating cancer, Alzheimer's disease, opioid withdrawal, pain and pet anxiety.Congress in December legalized CBD, or cannabidiol, derived from hemp. The FDA last year approved Epidiolex, a drug derived from CBD to treat severe forms of childhood epilepsy.

"Selling unapproved products with unsubstantiated therapeutic claims — such as claims that CBD products can treat serious diseases and conditions — can put patients and consumers at risk by leading them to put off important medical care," he said. The FDA said Curaleaf made "unfounded claims about more than a dozen different CBD products" on its product webpages, online store and social media websites. Some of the claims it highlighted include, "CBD has been demonstrated to have properties that counteract the growth of [and/or] spread of cancer" and "CBD has been linked to the effective treatment of Alzheimer's disease ….

Curaleaf has 15 days to respond to the FDA's concerns. Failure to correct the violations could result in legal action, such as product seizure or injunction, the agency said.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

CNBC /  🏆 12. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

New Beauty and Wellness Line Prima, by Honest Company Veterans, Aims to Rebrand CBDNew Beauty and Wellness Line Prima, by Honest Company Veterans, Aims to Rebrand CBDLaunching Wednesday, the brand has raised $3.25 million toward its mission of becoming a trusted go-to for safe, clean products in a crowded, confusing, unregulated space:
Baca lebih lajut »

Bayer, Battling Roundup Legal Claims, to Sell Dr. Scholl’sBayer, Battling Roundup Legal Claims, to Sell Dr. Scholl’sBayer, the German pharmaceuticals and chemicals group battling legal claims over its Roundup herbicide, will sell its Dr. Scholl’s foot-care business to Yellow Wood Partners for $585 million.
Baca lebih lajut »

Amazon warns consumers some Align Probiotic supplements sold were fakeAmazon warns consumers some Align Probiotic supplements sold were fake
Baca lebih lajut »

Amazon warns customers that Align supplements sold on its site are probably fakeAmazon warns customers that Align supplements sold on its site are probably fakeAmazon is advising customers to throw away certain nutritional supplements sold on its third-party marketplace.
Baca lebih lajut »

New Beauty and Wellness Line Prima, by Honest Company Veterans, Aims to Rebrand CBDNew Beauty and Wellness Line Prima, by Honest Company Veterans, Aims to Rebrand CBDLaunching Wednesday, the brand has raised $3.25 million toward its mission of becoming a trusted go-to for safe, clean products in a crowded, confusing, unregulated space:
Baca lebih lajut »



Render Time: 2025-03-06 12:10:32